Balance Sheet (USD $)	Oct. 31, 2011	Jul. 31, 2011
Current assets
Cash and cash equivalents	$ 12,585	$ 51,789
Total current assets	12,585	51,789
Other assets
Patents and patent applications (net of accumulated amortizaton)	25,672	25,926
Total assets	38,257	77,715
Liabilities
Accounts payable and accrued liabilities	27,362	104,136
Accrued salaries and wages	15,922	4,127
Due to related party	126,412	307,969
Convertible Notes Payable	100,000
Total liabilities	269,696	416,232
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 91,996,333 shares issued and outstanding at October 31, 2011 and 76,976,333 shares issued and outstanding at July 31, 2011	91,996	76,976
Additional paid-in capital	15,904,372	11,092,214
Accumulated deficit during the development stage	(16,227,807)	(11,507,707)
Total stockholders' equity (deficit)	(231,439)	(338,517)
Total liabilities and stockholders' equity	$ 38,257	$ 77,715